Nothing Special   »   [go: up one dir, main page]
Skip to main content
Springer Nature Link
Log in

Business Context-Based Approach for Managing the Digitalization of Biopharmaceutical Supply Chain Operational Requirements

  • Conference paper
  • First Online:
Advances in Production Management Systems. Production Management Systems for Responsible Manufacturing, Service, and Logistics Futures (APMS 2023)

Part of the book series: IFIP Advances in Information and Communication Technology ((IFIPAICT,volume 689))

  • 1556 Accesses

Abstract

The COVID-19 pandemic has brought to attention several supply chain challenges in the globalized biopharmaceutical industry. Demand fluctuations and the ability to effectively repurpose manufacturing facilities, and to dynamically adapt scheduling and capacity to respond to those fluctuations are among the important challenges. The biopharmaceutical industry is highly segmented by geography and competency. Companies often must cooperate with other companies dispersed across the globe. While the manufacturing of final products is concentrated in a few western locations, raw materials may come from other parts of the world and the final products have to be distributed globally. Such a diverse environment is further complicated by stringent regulatory requirements and the lack of standardization for many operational raw materials and customization of product recipes. Therefore, it is crucial to have an effective way to document and use the requirements of different supply chain actors. Still, the requirements are usually written in paper form where one actor specifies a set of rules that other actors must follow to communicate specific information effectively. Digitalization, while promising to address this issue, is a stumbling block because of the complexity of the biopharmaceutical industry. Motivated by this challenge, this paper critically evaluates the novel Business Context-based approach for effective (digitalization) management of supply chain (operational) requirements. Biopharmaceutical supply chain networking is used as a specific case study. The investigation results show that, with identified improvements, the approach has the potential to manage supply chain requirements effectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Notes

  1. 1.

    The proposed approach assumes a collection of standard components exists.

References

  1. 2022, Biopharmaceutical Market, Analysis Report and Region Forecast 2022 - 2030

    Google Scholar 

  2. Yaroson, E.V., Breen, L., Hou, J., Sowter, J.: Resilience Strategies and the Pharmaceutical Supply Chain: The Role of Agility in Mitigating Drug Shortages. In: Barbosa-Povoa, A.P., Jenzer, H., de Miranda, J.L. (eds.) Pharmaceutical Supply Chains-Medicines Shortages, pp. 249–256. Springer (2019)

    Chapter  Google Scholar 

  3. Tukamuhabwa, B.R., Stevenson, M., Busby, J., Zorzini, M.: Supply chain resilience: definition, review and theoretical foundations for further study. Int. J. Prod. Res. 53(18), 5592–5623 (2015)

    Article  Google Scholar 

  4. Pujawan, I.N., Bah, A.U.: Supply chains under COVID-19 disruptions: literature review and research agenda. Supply Chain Forum 23(1), 81–95 (2022)

    Article  Google Scholar 

  5. Erickson, J., et al.: End-to-end collaboration to transform biopharmaceutical development and manufacturing. Biotechnol. Bioeng. 118(9), 3302–3312 (2021)

    Article  Google Scholar 

  6. Reinhardt, I.C., Oliveira, D.J.C., Ring, D.D.T.: Current perspectives on the development of industry 4.0 in the pharmaceutical sector. J. Ind. Inf. Integr. 18, 100131 (2019)

    Google Scholar 

  7. Figura, M.: Express Pack: Real-Time Release of Raw Materials for the Biopharmaceutical Industry. https://oagiscore.atlassian.net/wiki/spaces/EXPKS/pages/4564287489/Express+Pack+Real-Time+Release+of+Raw+Materials+for+the+Biopharmaceutical+Industry. Accessed: 07 Mar 2023

  8. Score Open-Source Project https://oagiscore.org/. Accessed 29 Mar 2023

  9. Kulvatunyou, B. (Serm), Oh, H., Ivezic, N., Nieman, S.T.: Standards-based semantic integration of manufacturing information: past, present, and future. J. Manuf. Syst. 52, 184–197 (2018)

    Google Scholar 

  10. National Institute of Standards and Technology https://www.nist.gov/. Accessed 23 Jan 2023

  11. “Open Application Group Inc.” https://oagi.org/. Accessed: 23-Jan-2023

  12. “Biopharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028),” Mordor Intell. https://www.mordorintelligence.com/industry-reports/global-biopharmaceuticals-market-industry#:~:text=The biopharmaceuticals market is estimated,impact on the biopharmaceutical industry. Accessed: 29 Mar 2023

  13. Boehlje, M.: Structural changes in the agricultural industries: how do we measure, analyze and understand them? Am. J. Agric. Econ. 81(5), 1028–1041 (1999)

    Article  Google Scholar 

  14. Zamora, E.A.: Value chain analysis: a brief review. Asian J. Innov. Policy 5(2), 116–128 (2016)

    Article  Google Scholar 

  15. Hernández, V., Pedersen, T.: Global value chain configuration: a review and research agenda. BRQ Bus. Res. Q. 20(2), 137–150 (2017)

    Article  Google Scholar 

  16. Louis, B., Ruslan, R.: Global Value Chains and Smart Specialisation Strategy . Thematic Work on the Understanding of Global Value Chains and Their Analysis within the Context of Smart Specialisation . Global Value Chains and Smart Specialisation Strategy Thematic Work on The (2015)

    Google Scholar 

  17. Kim, Y.C., Atukeren, E., Lee, Y.: A new digital value chain model with PLC in biopharmaceutical industry: the implication for open innovation. J. Open Innov. Technol. Mark. Complex. 8(2), 63 (2022)

    Article  Google Scholar 

  18. Sim, C., Zhang, H., Chang, M.L.: “Improving end-to-end traceability and pharma supply chain resilience using blockchain”, blockchain healthc. Today 5, 1–10 (2022)

    Google Scholar 

  19. 2022, “Tools of Tomorrow,” CELL GENE Ther. INSIGHTS, 8(11)

    Google Scholar 

  20. Crawford, M.: Blockchain: Will It Transform the Pharmaceutical Supply Chain?,” GMP Publ (2018)

    Google Scholar 

  21. Elder, D.P., Kuentz, M., Holm, R.: Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur. J. Pharm. Sci. 87, 88–99 (2016)

    Article  Google Scholar 

  22. Pan, L.B.: Implementation Roadmap and Real Options Analysis for Biopharmaceutical Technology Introduction in Partial Fulfillment of the Requirements for the Degrees of Master of Business Administration and Master of Science in Chemical Engineering in Conjunction Wit (2013)

    Google Scholar 

  23. Lamberti, M.J., et al.: An examination of eclinical technology usage and CDISC standards adoption. Ther. Innov. Regul. Sci. 49(6), 869–876 (2015)

    Article  Google Scholar 

  24. Upton, J.: Setting Sights on the Smart Supply Chain. Pharm. Exec

    Google Scholar 

  25. Faridi, M.R., Malik, A.: Digital transformation in supply chain, challenges and opportunities in smes: a case study of al-rumman pharma. Emerald Emerg. Mark. Case Stud. 10(1), 1–16 (2020)

    Article  Google Scholar 

  26. Grossman, M., Bates, S.: Knowledge capture within the biopharmaceutical clinical trials environment. Vine 38(1), 118–132 (2008)

    Article  Google Scholar 

  27. USP-NF. https://www.uspnf.com/. Accessed: 29 Mar 2023

  28. European Pharmacopoeia. https://pheur.edqm.eu/home. Accessed: 29 Mar 2023

  29. Japanese Pharmacopoeia 18th Edition. https://www.pmda.go.jp/english/rs-sb-std/standards-development/jp/0029.html. Accessed: 29-Mar-2023

  30. British Pharmacopoeia. https://www.pharmacopoeia.com/. Accessed 29 Mar 2023

  31. 2020, Chinese Pharmacopoeia 2020 Edition: Key Points, Access Extra https://www.accestra.com/chinese-pharmacopoeia-2020-edition-key-points/. Accessed 10 Apr 2023

  32. Bucerius, M., 2020, “Riding China’s Regulatory Rapids,” Med. Mak. [Online]. Available: https://themedicinemaker.com/business-regulation/riding-chinas-regulatory-rapids. Accessed 29-Mar-2023

  33. Albanese, J.A., Wiggins, M.J.: A Case Study in Pharmacopoeia Compliance: Excipients and Raw Materials. BioPharm Int (2020)

    Google Scholar 

  34. Wiggins, J.M., Albanese, J.A.: Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon.

    Google Scholar 

  35. 2022, Thirteenth International Meeting of World Pharmacopoeias https://www.who.int/news-room/events/detail/2022/09/27/default-calendar/thirteenth-international-meeting-of-world-pharmacopoeias. Accessed 30 Mar 2023

  36. Schniepp, S. J.: ALCOA+ and Data Integrity, Pharm. Technol. p. 77

    Google Scholar 

  37. Alosert, H., et al.: Data integrity within the biopharmaceutical sector in the era of industry 4.0. Biotechnol. J. 17(6), 1–8 (2022)

    Article  Google Scholar 

  38. Markarian, J.: Tracking Raw Materials in Biopharma Manufacturing. Pharm. Technol., p. 54 (2019)

    Google Scholar 

  39. Pal, A., Kumar Rath, H., Shailendra, S., Bhattacharyya, A.: IoT Standardization: The Road Ahead, Internet of Things - Technology, Applications and Standardization, J. Sen, ed., BoD – Books on Demand, pp. 53–74 (2018)

    Google Scholar 

  40. Jain, T., Pandey, B.: Knowledge Management Implementation. BioPharm Int (2012)

    Google Scholar 

  41. 2009, Core Components Technical Specification CCTS, Version 3.0., p. 162 https://unece.org/DAM/cefact/codesfortrade/CCTS/CCTS-Version3.pdf. Accessed 10 Mar 2021

  42. Novakovic, D.: Business Context Aware Core Components Modeling, Vienna University of Technology (2014)

    Google Scholar 

  43. Ivezic, N., Jelisic, E., Jankovic, M., Kulvatunyou, B., Kehagias, D., and Marjanovic, Z.: Advancing Data Exchange Standards for Interoperable Enterprise Networks (2022)

    Google Scholar 

  44. Jelisic, E., Ivezic, N., Kulvatunyou, B., Milosevic, P., Babarogic, S., Marjanovic, Z.: A novel business context-based approach for improved standards-based systems integration—a feasibility study. J. Ind. Inf. Integr., 30(June) (2022)

    Google Scholar 

  45. 2011, The Rules Governing Medicinal Products in the European Union

    Google Scholar 

  46. 2021, What Changes When a Drug Candidate Moves from the Research Stage to GMP Production – and Why?. Biovian https://biovian.com/news/the-whys-and-the-whats-of-gmp-production-of-biopharmaceuticals/. Accessed: 07 Apr 2023

  47. Quinn, K.S.: A Holistic Approach to Raw Material Risk Assessments through Industry Collaboration (2019)

    Google Scholar 

  48. 2021, Index of World Pharmacopoeias and Pharmacopoeial Authorities

    Google Scholar 

  49. Jelisic, E., Ivezic, N., Kulvatunyou, B., Nieman, S., Marjanovic, Z.: Business Context-Based Quality Measures for Data Exchange Standards Usage Specification, Springer Cham, Valencia

    Google Scholar 

Download references

Disclaimer and Acknowledgement

Specific commercial systems and applications identified in this paper are not intended to imply recommendation or endorsement by the National Institute of Standards and Technology, nor is it intended to indicate that they are necessarily the best available for the purpose.

Author information

Authors and Affiliations

  1. Engineering Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA

    Elena Jelisic, Milos Drobnjakovic, Boonserm Kulvatunyou, Nenad Ivezic & Hakju Oh

  2. Faculty of Organizational Sciences, University of Belgrade, Belgrade, Serbia

    Elena Jelisic

Authors
  1. Elena Jelisic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milos Drobnjakovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Boonserm Kulvatunyou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nenad Ivezic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hakju Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Jelisic .

Editor information

Editors and Affiliations

  1. Norwegian University of Science and Technology, Trondheim, Norway

    Erlend Alfnes

  2. Norwegian University of Science and Technology, Trondheim, Norway

    Anita Romsdal

  3. Norwegian University of Science and Technology, Trondheim, Norway

    Jan Ola Strandhagen

  4. ZF Friedrichshafen AG, Friedrichshafen, Germany

    Gregor von Cieminski

  5. Tecnológico de Monterrey, Mexico City, Mexico

    David Romero

Rights and permissions

Reprints and permissions

Copyright information

© 2023 IFIP International Federation for Information Processing

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Jelisic, E., Drobnjakovic, M., Kulvatunyou, B., Ivezic, N., Oh, H. (2023). Business Context-Based Approach for Managing the Digitalization of Biopharmaceutical Supply Chain Operational Requirements. In: Alfnes, E., Romsdal, A., Strandhagen, J.O., von Cieminski, G., Romero, D. (eds) Advances in Production Management Systems. Production Management Systems for Responsible Manufacturing, Service, and Logistics Futures. APMS 2023. IFIP Advances in Information and Communication Technology, vol 689. Springer, Cham. https://doi.org/10.1007/978-3-031-43662-8_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-43662-8_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-43661-1

  • Online ISBN: 978-3-031-43662-8

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation